Related by context. Frequent words. (Click for all words.) 55 Hill Rom enhancing 54 By KRISTEN SENZ 53 preventing genital warts 53 Attention-Deficit/Hyperactivity Disorder ADHD 52 neuromotor 52 Zoraxel 52 Training Effectiveness 51 dietary interventions 51 immune modulating 51 By Laurelle Gilbert 51 BY VINCENT MAO 51 Search OrlandoSentinel.com Web 50 tolerability profiles 50 Search amNY.com Web 50 upper limb spasticity 50 ParaBody fitness equipment 50 pharmacoeconomic 50 psychosocial functioning 50 vitamin supplementation 49 Kathy Cloninger CEO 49 teriflunomide 49 SILENOR TM 49 Therein lurks 49 dosing frequency 49 REAs Rich Enterprise 49 pharmacological approaches 49 ADHD symptoms 49 Search Newsday.com Web 49 Secondary endpoints include 49 lipid profiles 49 tasimelteon 49 Nortel remedial 49 attention-deficit/hyperactivity disorder ADHD 48 clinically meaningful 48 Tranzeo optimum cost 48 bd.className = bd.className.replace overflow 48 inattention hyperactivity 48 pharmacokinetic PK 48 Nortel unfunded 48 reflux symptoms 48 Nominal GDP includes 48 onset puberty 48 Longitudinal studies 48 triglyceride lowering 48 mucosal healing 48 Records Philips Polydor 48 Tekamlo 47 % #F# 9v.jsn 47 Please respond insightfully 47 anti angiogenic drugs 47 SERCA2a 47 PURE proprietary 47 adenotonsillectomy 47 AMPAKINE 47 interpersonal psychotherapy 47 Matt Krupnick covers 47 sweat chloride 47 psychoeducational 47 Prodarsan ® 47 highly immunogenic 47 pharmacodynamic properties 47 STORY HOUR 47 sUA 47 By Mara Stine 47 neurocognitive function 47 Pharmacodynamic 46 Pharmacologic 46 posttest 46 Preschool storytime 46 psychotherapies 46 neuro developmental 46 ZFP Therapeutics 46 fluoride supplements 46 patient centeredness 46 erectile function 46 demonstrated statistically significant 46 cobiprostone 46 low toxicity bioscience 46 Depressive symptoms 46 Nortel strategic alliances 46 glucose homeostasis 46 tic disorders 46 adiponectin levels 46 SumTotal logo 46 By RYAN BOLAND 46 MoxDuo IR 46 attention-deficit/hyperactivity disorder 46 lowering triglycerides 46 partial onset seizures 46 neurological impairments 46 DXL# 46 methodologic 46 methodological limitations 46 AVI RNA based 46 psychoeducation 46 Chemophase 46 By Yoon Ja 46 SIRT1 activators 46 Exacerbations 46 pharmacokinetic parameters 46 pharmacokinetic pharmacodynamic